医学
肝移植
移植
重症监护医学
上市(财务)
肾移植
肝病
肾
内科学
财务
经济
作者
Erik L. Lum,Andrés Cárdenas,Paul Martin,Suphamai Bunnapradist
摘要
On August 10, 2017, a formal policy was enacted in the United States that defined listing criteria for simultaneous liver‐kidney transplantation and priority for patients who received a liver transplantation (LT) and subsequently developed significant kidney disease after LT. This article reviews and summarizes the rationale for such policies, the policies themselves, and the potential impact on LT candidates.
科研通智能强力驱动
Strongly Powered by AbleSci AI